UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis – Extended analysis of pirfenidone trial in Japan

Respiratory investigation, 2015-11, Vol.53 (6), p.271-278

2015

Volltextzugriff (PDF)

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Respiratory research, 2011-10, Vol.12 (1), p.143-143, Article 143

2011

Volltextzugriff (PDF)

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

Respiratory research, 2011-07, Vol.12 (1), p.93-93, Article 93

2011

Volltextzugriff (PDF)

Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides

Respirology (Carlton, Vic.), 2004-06, Vol.9 (2), p.190-196

2004

Volltextzugriff (PDF)

Promoter Analysis and Aberrant Expression of the MUC5B Gene in Diffuse Panbronchiolitis

American journal of respiratory and critical care medicine, 2005-05, Vol.171 (9), p.949-957

2005

Volltextzugriff (PDF)

Recurrence of Inflammatory Pseudotumor of the Lung after Eleven Years of Remission

Internal Medicine, 2009, Vol.48(12), pp.1079-1083

2009

Volltextzugriff (PDF)

Phase II Study of Area Under the Plasma-Concentration-Versus-Time Curve–Based Carboplatin Plus Standard-Dose Intravenous Etoposide in Elderly Patients With Small-Cell Lung Cancer

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3540-3545

1999

Volltextzugriff (PDF)

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2005-05, Vol.171 (9), p.1040-1047

2005

Volltextzugriff (PDF)

Fine Localization of a Major Disease-Susceptibility Locus for Diffuse Panbronchiolitis

American journal of human genetics, 2000-02, Vol.66 (2), p.501-507

2000

Volltextzugriff (PDF)

Hypoglycemia Induced by Secretion of High Molecular Weight Insulin-like Growth Factor-II from a Malignant Solitary Fibrous Tumor of the Pleura

Internal Medicine, 2001, Vol.40(4), pp.341-344

2001

Volltextzugriff (PDF)

Surgically Curable Peripheral Lung Carcinoma

Chest, 2005-03, Vol.127 (3), p.871-878

2005

Volltextzugriff (PDF)

Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis

American journal of respiratory and critical care medicine, 1998-09, Vol.158 (3), p.846-850

1998

Volltextzugriff (PDF)

Mutations in the SLC34A2 Gene Are Associated with Pulmonary Alveolar Microlithiasis

American journal of respiratory and critical care medicine, 2007-02, Vol.175 (3), p.263-268

2007

Volltextzugriff (PDF)

Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

Respirology (Carlton, Vic.), 2012-04, Vol.17 (3), p.467-477

2012

Volltextzugriff (PDF)

Successful Treatment of Refractory Bronchorrhea by Inhaled Indomethacin in Two Patients With Bronchioloalveolar Carcinoma

Chest, 1999-05, Vol.115 (5), p.1465-1468

1999

Volltextzugriff (PDF)

Multiple Atypical Adenomatous Hyperplasia with Synchronous Multiple Primary Bronchioloalveolar Carcinomas

Internal Medicine, 2002, Vol.41(6), pp.474-477

2002

Volltextzugriff (PDF)

Surgically curable peripheral lung carcinoma : Correlation of thin-section CT findings with histologic prognostic factors and survival

Chest, 2005-03, Vol.127 (3), p.871-878

2005

Volltextzugriff (PDF)

Efficacy of Gefitinib in a Patient with Lung Cancer Associated with Idiopathic Pulmonary Fibrosis

Journal of thoracic oncology, 2006-09, Vol.1 (7), p.733-734

2006

Volltextzugriff (PDF)

Efficacy of Gefitinib in a Patient with Lung Cancer Associated with Idiopathic Pulmonary Fibrosis

Journal of thoracic oncology, 2006-09, Vol.1 (7), p.733-734

2006

Volltextzugriff (PDF)

Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan

Respiratory investigation, 2015-11, Vol.53 (6), p.279-287

2015

Volltextzugriff (PDF)

Small lung tumors with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics

Lung cancer (Amsterdam, Netherlands), 2004-04, Vol.44 (1), p.43-51

2004

Volltextzugriff (PDF)

Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

Japanese journal of clinical oncology, 2001-10, Vol.31 (10), p.488-494

2001

Volltextzugriff (PDF)

Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients

PloS one, 2011-07, Vol.6 (7), p.e22062-e22062

2011

Volltextzugriff (PDF)

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data

Pharmacogenomics, 2011-07, Vol.12 (7), p.965-975

2011

Volltextzugriff (PDF)

Immunohistochemical Analysis of Tumorigenesis in the Fibrotic Lung

Haigan, 2000/12/20, Vol.40(7), pp.725-729

2000

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(196)

Publikationsform

Sprache

Englisch
(183)
Japanisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis – Extended analysis of pirfenidone trial in Japan

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides

Promoter Analysis and Aberrant Expression of the MUC5B Gene in Diffuse Panbronchiolitis

Recurrence of Inflammatory Pseudotumor of the Lung after Eleven Years of Remission

Phase II Study of Area Under the Plasma-Concentration-Versus-Time Curve–Based Carboplatin Plus Standard-Dose Intravenous Etoposide in Elderly Patients With Small-Cell Lung Cancer

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Fine Localization of a Major Disease-Susceptibility Locus for Diffuse Panbronchiolitis

Hypoglycemia Induced by Secretion of High Molecular Weight Insulin-like Growth Factor-II from a Malignant Solitary Fibrous Tumor of the Pleura

Surgically Curable Peripheral Lung Carcinoma

Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis

Mutations in the SLC34A2 Gene Are Associated with Pulmonary Alveolar Microlithiasis

Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

Successful Treatment of Refractory Bronchorrhea by Inhaled Indomethacin in Two Patients With Bronchioloalveolar Carcinoma

Multiple Atypical Adenomatous Hyperplasia with Synchronous Multiple Primary Bronchioloalveolar Carcinomas

Surgically curable peripheral lung carcinoma : Correlation of thin-section CT findings with histologic prognostic factors and survival

Efficacy of Gefitinib in a Patient with Lung Cancer Associated with Idiopathic Pulmonary Fibrosis

Efficacy of Gefitinib in a Patient with Lung Cancer Associated with Idiopathic Pulmonary Fibrosis

Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan

Small lung tumors with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics

Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data

Immunohistochemical Analysis of Tumorigenesis in the Fibrotic Lung

Suchergebnisse filtern